NASDAQ:CSBR

Champions Oncology Q2 2027 Earnings Date & Estimates

Champions Oncology logo
$4.34 -0.06 (-1.45%)
As of 03:58 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Champions Oncology is estimated to report Q2 2027 earnings on Tuesday, December 15, 2026, after market closes. The conference call is scheduled for December 14, 2026 at 4:30 PM ET.

Upcoming Earnings Announcement

Quarter
Q2 2027
Announcement Date
Time
After Market Closes
Conference Call Date
Conference Call
4:30 PM ET

What Analysts Expect from Champions Oncology in Q2 2027

Champions Oncology is expected to post earnings of $0.02 per share on revenue of $16.37 million. Champions Oncology last reported on September 10, 2026, posting $0.05 per share and beating the -$0.01 consensus estimate. Champions Oncology has beaten the consensus EPS estimate in 3 of its last 4 quarters.

Consensus Estimates

Consensus EPS
$0.02
Expected Revenue
$16.37 million

Recent Track Record

Last Reported
Q1 2027
Last Quarter EPS
$0.05 (Beat by +$0.06)
Last Quarter Revenue
$15.23 million
EPS Beat Rate
3 of last 4 quarters

Champions Oncology Q2 2027 Earnings FAQ

Champions Oncology (NASDAQ:CSBR) is estimated to report Q2 2027 earnings on Tuesday, December 15, 2026, after market closes. This date is estimated from past reporting schedules and may change once the company confirms it.

Champions Oncology's Q2 2027 earnings conference call is scheduled for Monday, December 14, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Champions Oncology to post earnings of $0.02 per share for Q2 2027.

The consensus revenue estimate for Champions Oncology is $16.37 million for Q2 2027.

Champions Oncology Earnings Headlines

Earn $4,500 a month? Your income may count for more
Earn $4,500 or more a month? Pennie lets you explore personal loan options that consider your income, not just your credit score. Options include personal loans up to $250,000 and APRs starting at 5.99%. Checking your rate is free, and the soft credit check won't affect your score. Pennie is a loan marketplace, not a lender. Offers come from third-party partners and are not guaranteed.tc pixel
See More Champions Oncology Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Champions Oncology? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Champions Oncology and other key companies, straight to your email.

About Champions Oncology

Champions Oncology (NASDAQ:CSBR) is a biotechnology company focused on cancer research and precision oncology. It develops and uses patient-derived tumor models and related technologies to study how cancers respond to treatments.

The company provides research services to biopharmaceutical firms developing cancer therapies, including preclinical testing and translational research. It also offers tumor-profiling and treatment-testing services intended to help physicians evaluate potential therapies for individual patients.

Champions Oncology was founded in 2007 and serves pharmaceutical and biotechnology customers as well as the oncology community. Its work centers on connecting laboratory research with clinical cancer care.

View Champions Oncology Profile